Search - tctmd.com

Displaying 21 - 40 of 99

Sort: Relevancy | Date

Presentation TCT 2023

TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation

Presenter: Matti Adam

October 25, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

Presentation TVT 2023

Left Ventricular Remodeling after JenaValve Trilogy Transcatheter Aortic Valve Replacement in Patients with Pure Aortic Regurgitation

Presenter: Lauren Ranard

June 09, 2023

Presentation TVT 2023

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

Presenter: Eberhard Grube

June 08, 2023

Presentation TVT 2023

JenaValve

Presenter: Matti Adam

June 08, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

Presentation TCT 2022

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

Presenter: Alexander R. Tamm

September 18, 2022

The Dedicated JenaValve TAVR System for AI: Early EU and US Experiences

Presentation TCT 2022

The Dedicated JenaValve TAVR System for AI: Early EU Experience

Presenter: Alexander Tamm

September 18, 2022

Presentation TCT 2022

TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

Presenter: Stanley Chetcuti

September 17, 2022

Presentation TCT 2022

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

Presenter: Lauren Ranard

September 17, 2022

Presentation TVT 2022

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

JenaValve to treat a degenerative regurgitant aortic valve following previous Ross procedure with no annular calcium.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Presentation TVT 2022

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

Presenter: Vinod Thourani

June 08, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

Advertisement

TCT 288: Implantation Depth and Need for Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the JenaValve System in Patients with Severe Aortic Regurgitation

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

What’s Going to Be Hot at TCT 2023

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

Left Ventricular Remodeling after JenaValve Trilogy Transcatheter Aortic Valve Replacement in Patients with Pure Aortic Regurgitation

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

JenaValve

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

The Dedicated JenaValve TAVR System for AI: Early EU Experience

TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

JenaValve to treat a degenerative regurgitant aortic valve following previous Ross procedure with no annular calcium.

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

TCTMD’s Top 10 Most Popular Stories for May 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content